Shir Bergson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shir Bergson has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Bar Manori
Tel Aviv University 2 Faculty of Medical and Health Sciences Tel Aviv
1 shared publication - Eli Sprecher
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
1 shared publication - Janan Mohamad
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
1 shared publication - Josefina Piñón Hofbauer
EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria
1 shared publication - Julia Illmer
EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria; Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria
1 shared publication - Karina Smorodinsky-Atias
School of Neurobiology, Biochemistry and Biophysics, Tel Aviv University 4 Faculty of Life Sciences Tel Aviv
1 shared publication
Latest Publications
- Open Access
- 20 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.
- 20 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
Open AccessHMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.